APPLICATION OF THE DRUG "TRAUMEL WITH" U SICK WITH PURENT- INFLAMMATORY DISEASES MAXILLOFACIAL AREA

Авторы

  • Nizom Sadriev Автор
  • Hasan Tilalov Автор
  • Kamola Toshpoʻlatova Автор
  • Dilshodjon Baxtiyorov Автор

DOI:

https://doi.org/10.5281/zenodo.10633800

Аннотация

Patients with purulent-inflammatory diseases of the maxillofacial area make up about 15-20 % of patients visiting dental clinics and more than 60% of patients receiving medical care in maxillofacial surgery departments . In patients hospitalized in departments with a diagnosis of abscess or phlegmon , there are from 35% to 70% of the total number of patients. According to various authors, from 30% to 40% of dental beds are for patients diagnosed with odontogenic osteomyelitis..

Опубликован

2024-02-07

Как цитировать

Sadriev , N. ., Tilalov , H. ., Toshpoʻlatova , K., & Baxtiyorov , D. (2024). APPLICATION OF THE DRUG "TRAUMEL WITH" U SICK WITH PURENT- INFLAMMATORY DISEASES MAXILLOFACIAL AREA. Центральноазиатский журнал междисциплинарных исследований и менеджмента, 1(1), 55-58. https://doi.org/10.5281/zenodo.10633800
Innovative Academy RSC
Article metrics Views and PDF downloads
0 Views
0 Downloads